Animal pharmacokinetics and interspecies scaling of sordarin derivatives following intravenous administration

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 10, 2001, Pages 2787-2792

  Aviles, P ^a   Pateman, A ^a   Roman, R S ^a   Guillen, M J ^a   De las Heras, F G ^a   Gargallo Viola, D ^a  

^a GLAXOSMITHKLINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; GM 193663; GM 237354; SORDARIN DERIVATIVE;

ALLOMETRY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANDIDA ALBICANS; COCCIDIOIDES IMMITIS; CONTROLLED STUDY; CORRELATION FUNCTION; DOSE RESPONSE; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; HISTOPLASMA CAPSULATUM; LIVER BLOOD FLOW; LIVER FUNCTION TEST; MONKEY; MOUSE; MYCOSIS; NONHUMAN; PNEUMOCYSTIS CARINII; PREDICTION; PRIORITY JOURNAL; RABBIT; RAT; REGRESSION ANALYSIS; SPECIES DIFFERENCE;

ANIMALS; ANTIBIOTICS, ANTIFUNGAL; BINDING SITES; BLOOD PROTEINS; INDENES; INFUSIONS, INTRAVENOUS; MALE; MICE; MODELS, ANIMAL; PROTEIN SYNTHESIS INHIBITORS;

EID: 0034812539     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.10.2787-2792.2001     Document Type: Article

References (25)

1. Pharmacokinetics-pharmacodynamics of a sordarin derivative (GM-237354) in a murine model of lethal candidiasis
2. In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats
3. Interspecies scaling, allometry, physiological time and the ground plan of pharmacokinetics
4. Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm
5. Efficacies of sordarin derivatives GM193663, GM211676, and GM237354 in a murine model of systemic coccidioidomycosis
6. Physiological parameters in laboratory animals and humans
7. Biotransformation and toxicity of acetaminophen in congenic RHA rats with or without a hereditary deficiency in bilirubin UDP-glucuronosyltransferase
8. Identification of elongation factor 2 as the essential protein targeted by sordarins in Candida albicans
9. Sordarins: A new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts
10. Role of pharmacokinetics in the outcome of infections
11. International conference for the development of a consensus on the management and prevention of severe candidal infections
12. Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model
13. Activities of sordarins in murine histoplasmosis
14. Sordarins: In vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi
15. Tail sectioning: A rapid and simple method for repeated blood sampling of the rat for cortisone determination
16. Antifungal prophylaxis during neutropenia and immunodeficiency
17. Pharmacodynamics of fluconazole in a murine model of systemic candidiasis
18. Differences in UDP-glucuronosyl transferase activities in congenic inbred rats homozygous and heterozygous for the jaundice locus
19. Activities of sordarins in experimental models of candidiasis, aspergillosis, and pneumocystosis
20. Furosemide binding to human albumin and plasma of nephrotic children
21. The significance of the relationship between tissue: Serum ratios, tissue concentrations and the location of microorganisms
22. Correlation of pharmacodynamic parameters of five betalactam antibiotics with therapeutic efficacies in an animal model
23. Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo
24. Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients
25. Catheterisation of the jugular vein